NFS1 and colorectal cancer: Cysteine desulfurase (NFS1) deficiency significantly enhanced the sensitivity of colorectal cancer cells to oxaliplatin due to the synergistic effect of NFS1 deficiency with oxaliplatin treatment, triggering PANoptosis by increasing intracellular levels of reactive oxygen species (125).